John Locke Foundation: Prudent Policy / Impeccable Research - Volume DCXCVII | Eastern NC Now

We will offer this allotment of three with more to come; some old, most new, but all quite informative, and, moreover, necessary to understanding that in North Carolina, there is a wiser path to govern ourselves and our People.

ENCNow
Home
Categories
Login
Advertisement
VbAD0
Latest Polls   (view all)
Where do you stand on the Transgender Issue now that the issue has gotten to the overt point of the open celebration of this lifestyle choice, dictated by certain direct and explicit actions.
85.71% I do not approve of behavior that has within its expressed tenants policies that harm children.
12.86% I do support the Trans Community in all its many facets because diversity is at a premium in today's society.
1.43% What is a "Children's Drag Queen Story Hour?"
Advertisement
VbAD1
Latest Comments   (view all)
Advertisement
VbAD2
Latest Entries   (view all)
Advertisement
O2bAD0
ENCN Masthead
ENCN Masthead
Go Back


Leave a Guest Comment

Your Name or Alias
Your Email Address ( your email address will not be published )
Enter Your Comment ( text only please )




N.C. Has a State-Certified COVID-19 Vaccination Card. What’s That Mean? John Locke Foundation Guest Editorial, Editorials, Op-Ed & Politics Tenure Troubles Extend to Harvard, Cornel West


HbAD0

Latest Op-Ed & Politics

"Pay no attention to the folks behind the curtain" was their preference but things are beginning to come to light.
Understanding how parties work is important for making informed decisions regarding elected officials.
"They help cultivate a radical hate America agenda, and we can't afford that same toxic ideology in America's War Department.”
The attack comes amid a heightened concern over terror attacks after President Donald Trump launched "Operation Epic Fury" in Iran.

HbAD1

Beaufort County residents deserve lower taxes and should demand them from government.
illegal alien "asylum seeker" migrants are a crime wave on both sides of the Atlantic

HbAD2

 
 
Back to Top